Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1238225.RAVqVIwHeAMi2s7o-IUr_m8WzoPiIuvw_DBVvs9WpuQRE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1238225.RAVqVIwHeAMi2s7o-IUr_m8WzoPiIuvw_DBVvs9WpuQRE130_assertion type Assertion NP1238225.RAVqVIwHeAMi2s7o-IUr_m8WzoPiIuvw_DBVvs9WpuQRE130_head.
- NP1238225.RAVqVIwHeAMi2s7o-IUr_m8WzoPiIuvw_DBVvs9WpuQRE130_assertion description "[In conclusion, the results of the present study demonstrated that PI3K/AKT and Rab25 significantly contributed to cisplatin resistance in human epithelial ovarian cancer; in addition, silencing Rab25 or inhibiting the PI3K/AKT pathway markedly increased the sensitivity of these cells to cisplatin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238225.RAVqVIwHeAMi2s7o-IUr_m8WzoPiIuvw_DBVvs9WpuQRE130_provenance.
- NP1238225.RAVqVIwHeAMi2s7o-IUr_m8WzoPiIuvw_DBVvs9WpuQRE130_assertion evidence source_evidence_literature NP1238225.RAVqVIwHeAMi2s7o-IUr_m8WzoPiIuvw_DBVvs9WpuQRE130_provenance.
- NP1238225.RAVqVIwHeAMi2s7o-IUr_m8WzoPiIuvw_DBVvs9WpuQRE130_assertion SIO_000772 25405658 NP1238225.RAVqVIwHeAMi2s7o-IUr_m8WzoPiIuvw_DBVvs9WpuQRE130_provenance.
- NP1238225.RAVqVIwHeAMi2s7o-IUr_m8WzoPiIuvw_DBVvs9WpuQRE130_assertion wasDerivedFrom befree-2016 NP1238225.RAVqVIwHeAMi2s7o-IUr_m8WzoPiIuvw_DBVvs9WpuQRE130_provenance.
- NP1238225.RAVqVIwHeAMi2s7o-IUr_m8WzoPiIuvw_DBVvs9WpuQRE130_assertion wasGeneratedBy ECO_0000203 NP1238225.RAVqVIwHeAMi2s7o-IUr_m8WzoPiIuvw_DBVvs9WpuQRE130_provenance.